Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients

Objective. To investigate the efficacy and safety of the treatment of the newly diagnosed multiple myeloma (MM) patients with the therapy of subcutaneous (subQ) administration of bortezomib and dexamethasone plus thalidomide (VTD) regimen. Methods. A total of 60 newly diagnosed MM patients were anal...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Biomed Res Int
Huvudupphovsmän: Wu, Shenghao, Zheng, Cuiping, Chen, Songyan, Cai, Xiaoping, Shi, Yuejian, Lin, Bijing, Chen, Yuemiao
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi Publishing Corporation 2015
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4575715/
https://ncbi.nlm.nih.gov/pubmed/26425561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/927105
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk